Company News

New vaccine concept against SARS-CoV-2 successfully tested

5 June 2023

Swiss Rockets AG Welcomes Three New Key Members To The Team

18 April 2023

RocketVax Nasal Vaccine to Prevent COVID-19 Passes First Tests

4 April 2023

CNN Health Reports About RocketVax Covid-19 Nasal Vaccine

3 April 2023

RocketVax has successfully completed another round of financing; The development of the second-generation COVID-19 vaccine moves forward

6 February 2023

Volker Thiel: "Wir planen noch besseren Corona-Impfschutz"

15 November 2022

RocketVax AG Announces New Milestones in the Development of Second-Generation COVID-19 Vaccines

23 September 2022

Dr. Vladimir Cmiljanovic is a recipient of the 2023 Nikola Tesla Spirit Award

31 January 2023

Burkhard Frey joins Rocketvax AG as Chief Commercial Officer

22 August 2022

SRF: Research on nasal corona vaccines raises hopes

22 August 2022

Dr. Milan Crnogorac joins RocketVax AG as Chief Technology Officer

9 August 2022

Bilanz: Important Milestone

28 June 2022

Finanz und Wirtschaft: Doubts about the market for corona boosters

24 June 2022

RocketVax SARS-CoV-2 Vaccine (RVX-sCPD9) Significantly Outperforms mRNA and Adenovirus Vector-Based Technologies in Animal Models

9 June 2022

Swiss vaccine candidates enter clinical trial phase

28 March 2022